GW Pharmaceuticals - 株価

GWPH

214.94

毎日の変更:

0.36%

毎年:

122.14%

価格 日 年
Acadia Pharmaceuticals 48.98 3.16 6.90% 16.87%
Acorda Therapeutics 5.22 -1.56 -23.01% 346.15%
Adamas Pharmaceuticals 4.74 0.04 0.85% 21.85%
Aerie Pharmaceuticals 18.75 -0.50 -2.60% 23.68%
Agios Pharmaceuticals 48.89 1.56 3.30% 4.24%
ALKERMES 19.24 1.03 5.66% 0.92%
Alnylam Pharmaceuticals 143.39 6.02 4.38% 26.46%
Alexion Pharmaceuticals 150.10 1.64 1.10% 63.19%
Biogen 270.71 7.14 2.71% -14.86%
Bluebird Bio 28.68 0.74 2.65% -57.92%
BioMarin Pharmaceutical 77.73 1.38 1.81% -17.55%
Clovis Oncology 5.58 -0.08 -1.41% -29.01%
Flexion Therapeutics 11.44 -0.03 -0.26% -20.99%
GW Pharmaceuticals 214.94 0.77 0.36% 122.14%
Heron Therapeutics 17.49 0.54 3.19% 5.87%
Intercept Pharmaceuticals 20.66 1.33 6.88% -77.40%
YTE 80.26 2.76 3.56% 5.55%
Ionis Pharmaceuticals 52.68 1.29 2.52% -1.73%
Moderna Inc 131.97 -0.34 -0.25% 345.68%
Neurocrine Biosciences 93.23 0.26 0.28% 0.18%
Puma Biotechnology 10.86 0.16 1.50% 3.72%
Prothena 21.37 0.19 0.90% 104.89%
PTC Therapeutics 60.14 2.27 3.92% 9.23%
Ultragenyx Pharmaceutical 118.50 -0.13 -0.11% 135.49%
Regeneron Pharmaceuticals 461.57 12.19 2.71% -6.65%
Sarepta Therapeutics 84.79 2.63 3.20% -27.59%
Vertex Pharmaceuticals 211.98 4.19 2.02% -9.22%
Zogenix 20.74 0.48 2.37% -14.44%

価格 日 年
NASDAQ 12920 196.68 1.55% 50.66%

GWPH:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
収益へのPE価格
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者